Go Pro

Perspective Therapeutics (CATX) Institutional Ownership

Perspective Therapeutics logo
$3.41 -0.14 (-3.94%)
Closing price 06/30/2026 04:10 PM Eastern
Extended Trading
$3.44 +0.03 (+0.85%)
As of 06/30/2026 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Perspective Therapeutics (NYSEAMERICAN:CATX)

Current
Institutional Ownership
Percentage
54.66%
Number of
Institutional Buyers
(last 12 months)
51
Total
Institutional Inflows
(last 12 months)
$98.22M
Number of
Institutional Sellers
(last 12 months)
28
Total
Institutional Outflows
(last 12 months)
$15.89M
Get CATX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Perspective Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CATX Institutional Buying and Selling by Quarter

Perspective Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/4/2026Seven Fleet Capital Management LP379,082$1.58M0.5%N/A0.332%
5/28/2026Avidity Partners Management LP6,049,999$25.23M5.0%+88.4%5.305%
5/19/2026Bank of America Corp DE241,924$1.01M0.0%-43.0%0.212%
5/19/2026Ally Bridge Group NY LLC926,557$3.86M3.1%N/A0.812%
5/18/2026Yu Fan1,055,409$4.40M4.5%N/A0.925%
5/18/2026ADAR1 Capital Management LLC749,335$3.13M0.2%+687.2%0.657%
5/16/2026Quantinno Capital Management LP65,494$273K0.0%N/A0.057%
5/15/2026Commodore Capital LP6,336,782$26.42M1.5%N/A5.556%
5/15/2026Octagon Capital Advisors LP791,555$3.30M0.4%N/A0.694%
5/15/2026Affinity Asset Advisors LLC3,164,582$13.20M0.7%+954.9%2.775%
5/15/2026Spruce Street Capital LP2,627,107$10.96M2.6%N/A2.303%
5/7/2026Dimensional Fund Advisors LP450,097$1.88M0.0%+391.6%0.395%
5/5/2026Bank of New York Mellon Corp185,335$773K0.0%-1.7%0.163%
4/28/2026Abel Hall LLC11,794$49K0.0%N/A0.010%
4/21/2026Wealth Effects LLC33,000$138K0.0%+32.0%0.029%
3/3/2026Caitong International Asset Management Co. Ltd30,627$84K0.0%N/A0.041%
2/18/2026XTX Topco Ltd82,476$227K0.0%+36.5%0.111%
2/18/2026nVerses Capital LLC11,420$31K0.1%N/A0.015%
2/18/2026Sphera Funds Management LTD.349,973$962K0.2%-31.4%0.471%
2/18/2026Opaleye Management Inc.1,184,500$3.26M0.4%N/A1.593%
2/18/2026Millennium Management LLC1,406,374$3.87M0.0%-45.1%1.892%
2/18/2026Engineers Gate Manager LP12,562$35K0.0%N/A0.017%
2/17/2026ADAR1 Capital Management LLC95,193$262K0.0%N/A0.128%
2/17/2026Schonfeld Strategic Advisors LLC62,370$172K0.0%N/A0.084%
2/17/2026Graham Capital Management L.P.80,193$221K0.0%+76.8%0.108%
2/16/2026Avidity Partners Management LP3,210,733$8.83M2.5%+7.2%4.319%
2/16/2026Barclays PLC92,791$255K0.0%+10.7%0.125%
2/16/2026Aigen Investment Management LP10,173$28K0.0%N/A0.014%
2/13/2026Marshall Wace LLP406,732$1.12M0.0%N/A0.547%
2/13/2026The Manufacturers Life Insurance Company 19,031$52K0.0%-10.6%0.026%
2/13/2026Walleye Capital LLC328,667$904K0.0%-39.8%0.442%
2/13/2026State Street Corp1,141,247$3.14M0.0%+3.3%1.535%
2/13/2026Vontobel Holding Ltd.25,000$69K0.0%+25.0%0.034%
2/13/2026Caitong International Asset Management Co. Ltd15,208$42K0.1%N/A0.020%
2/13/2026Wells Fargo & Company MN66,820$184K0.0%+46.2%0.090%
2/12/2026MetLife Investment Management LLC16,717$46K0.0%-43.4%0.022%
2/12/2026Renaissance Technologies LLC352,493$969K0.0%N/A0.474%
2/12/2026Dimensional Fund Advisors LP91,557$252K0.0%N/A0.123%
2/12/2026Federated Hermes Inc.213,759$588K0.0%+7.9%0.288%
2/12/2026Patient Square Capital LP1,132,815$3.12M0.7%+224.3%1.524%
Read now. Do not delete. You’ve been warned. (Ad)

Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel

Don’t be left behind. Click here now.
2/12/2026Nuveen LLC1,274,007$3.50M0.0%-2.6%1.714%
2/11/2026Deutsche Bank AG54,245$149K0.0%+6.1%0.073%
2/10/2026Goldman Sachs Group Inc.159,837$440K0.0%-19.2%0.215%
2/10/2026AXQ Capital LP12,749$35K0.0%+24.2%0.017%
2/10/2026Intech Investment Management LLC25,702$71K0.0%-14.1%0.035%
2/9/2026Geode Capital Management LLC1,414,522$3.89M0.0%-1.3%1.903%
2/5/2026Hills Bank & Trust Co938,200$2.58M0.2%-4.2%1.262%
1/30/2026R Squared Ltd15,991$44K0.0%N/A0.022%
1/29/2026UBS Group AG926,331$2.55M0.0%+44.5%1.246%
1/21/2026Trueblood Wealth Management LLC119,061$327K0.1%+72.4%0.160%
1/16/2026Taylor & Morgan Wealth Management LLC97,000$267K0.1%+6.6%0.130%
1/14/2026Auctus Advisors LLC31,673$87K0.1%N/A0.043%
1/1/2026JPMorgan Chase & Co.436,357$1.50M0.0%-41.7%0.587%
11/17/2025Susquehanna International Group LLP51,304$176K0.0%-55.9%0.069%
11/17/2025Sherbrooke Park Advisers LLC32,425$111K0.1%N/A0.044%
11/17/2025Qube Research & Technologies Ltd68,959$237K0.0%-27.2%0.093%
11/17/2025Mariner LLC86,116$295K0.0%+33.6%0.116%
11/17/2025Mercer Global Advisors Inc. ADV29,275$100K0.0%+81.8%0.039%
11/17/2025Millennium Management LLC2,561,112$8.79M0.0%-1.3%3.449%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.27,986$96K0.0%-14.2%0.038%
11/17/2025Bank of America Corp DE785,823$2.70M0.0%+139.9%1.058%
11/14/2025Two Sigma Investments LP519,668$1.78M0.0%-13.6%0.700%
11/14/2025Bridgeway Capital Management LLC95,800$329K0.0%-13.5%0.129%
11/13/2025UBS Group AG641,143$2.20M0.0%+72.0%0.863%
11/13/2025BNP Paribas Financial Markets103,736$356K0.0%-57.2%0.140%
11/13/2025Russell Investments Group Ltd.8,449$29K0.0%+184.1%0.011%
11/12/2025Intech Investment Management LLC29,924$103K0.0%-23.3%0.040%
11/10/2025AXQ Capital LP10,268$35K0.0%-49.9%0.014%
11/10/2025Patient Square Capital LP349,323$1.20M0.3%N/A0.470%
11/10/2025Siligmueller & Norvid Wealth Advisors LLC164,711$565K0.3%N/A0.222%
11/7/2025Vanguard Group Inc.3,437,865$11.79M0.0%+5.0%4.629%
11/7/2025JPMorgan Chase & Co.436,357$1.50M0.0%-41.7%0.588%
10/23/2025SG Americas Securities LLC13,538$46K0.0%N/A0.018%
10/15/2025Taylor & Morgan Wealth Management LLC91,000$312K0.2%-3.2%0.123%
10/9/2025Voya Investment Management LLC10,675$37K0.0%-35.5%0.014%
8/15/2025Engineers Gate Manager LP28,708$99K0.0%-75.9%0.039%
8/15/2025BNP Paribas Financial Markets242,610$835K0.0%+227.1%0.327%
8/15/2025Bridgeway Capital Management LLC110,800$381K0.0%-11.4%0.149%
8/15/2025Bank of America Corp DE327,500$1.13M0.0%+8.5%0.441%
8/14/2025Qube Research & Technologies Ltd94,693$326K0.0%-22.4%0.128%
8/14/2025Federated Hermes Inc.195,080$671K0.0%+44.4%0.263%
8/13/2025Affinity Asset Advisors LLC1,050,000$3.61M0.5%-52.8%1.415%
8/13/2025Marshall Wace LLP520,707$1.79M0.0%-54.1%0.701%
8/13/2025Walleye Capital LLC187,403$645K0.0%+375.8%0.252%
8/12/2025Rhumbline Advisers83,250$286K0.0%-15.2%0.112%
8/12/2025JPMorgan Chase & Co.748,067$2.57M0.0%+118.4%1.008%
8/8/2025Citizens Financial Group Inc. RI53,100$183K0.0%-46.9%0.072%
8/8/2025Geode Capital Management LLC1,382,814$4.76M0.0%+15.8%1.863%
8/7/2025Los Angeles Capital Management LLC17,595$61K0.0%N/A0.024%
8/5/2025Hills Bank & Trust Co984,200$3.39M0.2%-3.9%1.326%
Read now. Do not delete. You’ve been warned. (Ad)

Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel

Don’t be left behind. Click here now.
7/31/2025Ground Swell Capital LLC16,373$56K0.1%N/A0.022%
7/29/2025Nicholson Wealth Management Group LLC1,614,283$5.55M3.4%+0.3%2.175%
7/23/2025Trueblood Wealth Management LLC69,061$238K0.1%+210.6%0.093%
7/15/2025Wealth Effects LLC24,000$83K0.0%-38.5%0.032%
7/7/2025Taylor & Morgan Wealth Management LLC94,000$323K0.2%+4.4%0.127%
6/27/2025Goldman Sachs Group Inc.302,819$645K0.0%-66.5%0.408%
5/16/2025Octagon Capital Advisors LP2,250,000$4.79M0.5%-2.4%3.038%
5/16/2025Goldman Sachs Group Inc.302,819$645K0.0%-66.5%0.409%
5/15/2025Cubist Systematic Strategies LLC51,480$110K0.0%-80.3%0.070%
5/14/2025Affinity Asset Advisors LLC2,224,196$4.74M0.5%+71.1%3.004%


CATX Institutional Ownership - Frequently Asked Questions

During the previous two years, 126 institutional investors and hedge funds held shares of Perspective Therapeutics. The most heavily invested institutionals were FMR LLC ($73.49M), Commodore Capital LP ($26.42M), Avidity Partners Management LP ($25.23M), Affinity Asset Advisors LLC ($13.20M), Vanguard Group Inc. ($11.79M), Spruce Street Capital LP ($10.96M), and Deerfield Management Company L.P. Series C ($9.38M).Learn more on Perspective Therapeutics' institutional investors.

54.66% of Perspective Therapeutics' stock is owned by institutional investors. Learn more on CATX's institutional investor holdings.

Of the 106 institutional investors that purchased Perspective Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Commodore Capital LP ($6.34M), FMR LLC ($5.37M), Affinity Asset Advisors LLC ($4.59M), Avidity Partners Management LP ($3.06M), Spruce Street Capital LP ($2.63M), Octagon Capital Advisors LP ($1.67M), and Nicholson Wealth Management Group LLC ($1.61M).

Institutional investors have bought a total of 25,306,921 shares in the last 24 months. This purchase volume represents approximately $98.22M in transactions.

Of the 28 institutional investors that sold Perspective Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($1.19M), Affinity Asset Advisors LLC ($1.17M), JPMorgan Chase & Co. ($623.42K), Marshall Wace LLP ($614.74K), Walleye Capital LLC ($217.37K), Bank of America Corp DE ($182.60K), and Sphera Funds Management LTD. ($160.37K).

Institutional investors have sold a total of 4,921,553 shares in the last 24 months. This volume of shares sold represents approximately $15.89M in transactions.



This page (NYSEAMERICAN:CATX) was last updated on 7/1/2026 by MarketBeat.com Staff.
From Our Partners